Stay updated with breaking news from Micha Breakstone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Somite Therapeutics, a tech-bio company harnessing big data and AI to pioneer novel cell replacement therapies, is thrilled to announce the...
Jensen Huang: "For the very first time in human history, biology has the opportunity to be engineering, not science."
Somite.ai aims to improve the lives of millions of people by leveraging AI to produce human tissue for cell therapies.
NeuroSense entered into a securities purchase agreement with a single health-care focused investor for 3,000,000 ordinary shares
NeuroSense says as a novel combination therapy of two FDA approved drugs, celecoxib and ciprofloxacin, with well-established safety profiles